GRB2 and inflammatory breast carcinoma: Fares et al. (2019) reported a higher prevalence of HCMV DNA in inflammatory breast carcinoma (IBC) compared to non-inflammatory BC (78.6% vs. 21.4%; p = 0.030), and they noted a significant increase in Grb2 mRNA expression in HCMV-positive IBC samples [112].